Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dryello Jock Itch
- Development stage
- Preclinical
- Lead developer
- ProPedix
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Dryello Jock Itch is a topical stick formulation in development by ProPedix for the treatment of jock itch (tinea cruris). Developed using ProPedix's proprietary DryStik Technology Platform, the product is designed as a convenient, no-touch, dry-application stick that delivers an antifungal treatment while keeping the affected area dry. It is planned for rollout in 2026 with specific formulations for both men and women.
- Brand names
- Dryello Jock Itch
02
Targets
SQLE (Squalene monooxygenase)
Beyond the preview
Go deeper on Dryello Jock Itch.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dryello Jock Itch.